Company Overview of Neotropix, Inc.
Neotropix, Inc., a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers. It develops NTX010, a naturally-occurring virus that attacks and kills neuroendocrine cancers, such as small cell lung cancer, small cell carcinomas originating in other organs, carcinoid, neuroblastoma, and certain other neuroendocrine cancers. The company was founded in 2003 and is headquartered in Malvern, Pennsylvania.
351 Phoenixville Pike
Malvern, PA 19355
Founded in 2003
Key Executives for Neotropix, Inc.
Similar Private Companies By Industry
|Vitalife, Inc.||United States|
|Bridgesite Clinical Research||United States|
|Praelux Inc.||United States|
|Sprout Pharmaceuticals, Inc.||United States|
|Helsinn Therapeutics (U.S.), Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Neotropix, Inc., please visit www.neotropix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.